Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 27 results.
User Information
Export Records
  1. 1.   Oncogenic HPV promotes the expression of the long noncoding RNA lnc-FANCI-2 through E7 and YY1
  2. Liu,Haibin; Xu, Junfen; Yang, Yanqin; Wang, Xiaohong; Wu, Ethan; Majerciak,Vladimir; Zhang, Tingting; Steenbergen, Renske D M; Wang, Hsu-Kun; Banerjee, Nilam S; Li, Yang; Lu, Weiguo; Meyers, Craig; Zhu, Jun; Xie, Xing; Chow, Louise T; Zheng,Zhi-Ming
  3. Proceedings of the National Academy of Sciences of the United States of America. 2021, Jan 19; 118(3):
  1. 2.   Structural basis for DNA damage-induced phosphoregulation of MDM2 RING domain
  2. Magnussen, Helge M.; Ahmed, Syed F.; Sibbet, Gary J.; Hristova, Ventzislava A.; Nomura, Koji; Hock, Andreas K.; Archibald, Lewis J.; Jamieson, Andrew G.; Fushman, David; Vousden, Karen H.; Weissman, Allan M.; Huang, Danny T.
  3. Nature communications. 2020, Apr 29; 11(1):
  1. 3.   Genome-Wide Profiling of Cervical RNA-Binding Proteins Identifies Human Papillomavirus Regulation of RNASEH2A Expression by Viral E7 and E2F1
  2. Xu, Junfen; Liu, Habin; Yang, Yanqin; Wang, Xiaohong; Liu, Poching; Li, Yang; Meyers, Craig; Banerjee, Nilam Sanjib; Wang, Hsu-Kun; Cam, Maggie; Lu, Weiguo; Chow, Louise T.; Xie, Xing; Zhu, Jun; Zheng,Zhi-Ming
  3. MBIO. 2019, Jan-Feb; 10(1):
  1. 4.   Clinical evaluation of human papillomavirus 16/18 oncoprotein test for cervical cancer screening and HPV positive women triage
  2. Yu, Lulu; Jiang, Mingyue; Qu, Pengpeng; Wu, Zeni; Sun, Peisong; Xi, Mingrong; Qin, Yu; Liu, Xin; Liao, Guangdong; Lei, Xiaoqin; Sun, Lixin; Zhang, Yongzhen; Li, Zhifang; Chen, Wen; Qiao, You-Lin
  3. International Journal of Cancer. 2018, Aug 15; 143(4): 813-822.
  1. 5.   Towards inferring time dimensionality in protein-protein interaction networks by integrating structures: the p53 example
  2. Tuncbag, N.; Kar, G.; Gursoy, A.; Keskin, O.; Nussinov, R.
  3. Molecular Biosystems. 2009 5(12): 1770-1778.
  1. 6.   Discovery of new pyridoacridine alkaloids from Lissoclinum cf. badium that inhibit the ubiquitin ligase activity of Hdm2 and stabilize p53
  2. Clement, J. A.; Kitagaki, J.; Yang, Y.; Saucedo, C. J.; O'Keefe, B. R.; Weissman, A. M.; Mckee, T. C.; McMahon, J. B.
  3. Bioorganic & Medicinal Chemistry. 2008 16(23): 10022-10028.
  1. 7.   Identification of inhibitors to papillomavirus type 16 E6 protein based on three-dimensional structures of interacting proteins
  2. Baleja, J. D.; Cherry, J. J.; Liu, Z. G.; Gao, H.; Nicklaus, M. C.; Voigt, J. H.; Chen, J. J.; Androphy, E. J.
  3. Antiviral Research. 2006, Oct; 72(1): 49-59.
  1. 8.   Oncogenic met receptor induces cell-cycle progression in Xenopus oocytes independent of direct Grb2 and shc binding or Mos synthesis, but requires phosphatidylinositol 3-kinase and Raf signaling
  2. Mood, K.; Saucier, C.; Ishimura, A.; Bong, Y. S.; Lee, H. S.; Park, M.; Daar, I. O.
  3. Journal of Cellular Physiology. 2006, APR; 207(1): 271-285.
  1. 9.   HDM2 phosphorylation by MAPKAP kinase 2
  2. Weber, H. O.; Ludwig, R. L.; Morrison, D.; Kotlyarov, A.; Gaestel, M.; Vousden, K. H.
  3. Oncogene. 2005, MAR 17; 24(12): 1965-1972.
  1. 10.   Nuclear accumulation of epidermal growth factor receptor and acceleration of G1/S stage by Epstein-Barr-encoded oncoprotein latent membrane protein 1
  2. Tao, Y. G.; Xing, S.; Deng, X. Y.; Xie, D. X.; Lee, L. M.; Liu, Y. P.; Wei, L.; Li, L. L.; Lin, D.; Qiao, W.; Gong, J. P.; Ya, C.
  3. Experimental Cell Research. 2005, FEB 15; 303(2): 240-251.
  1. 11.   Assay for ubiquitin ligase activity: High-throughput screen for inhibitors of HDM2
  2. Davydov, I. V.; Woods, D.; Safiran, Y. J.; Oberoi, P.; Fearnhead, H. O.; Fang, S.; Jensen, J. P.; Weissman, A. M.; Kenten, J. H.; Vousden, K. H.
  3. Journal of Biomolecular Screening. 2004, DEC; 9(8): 695-703.
  1. 12.   BCL-3 and NF-kappa B p50 attenuate lipopolysaccharide-induced inflammatory responses in macrophages
  2. Wessells, J.; Baer, M.; Young, H. A.; Claudio, E.; Brown, K.; Siebenlist, U.; Johnson, P. F.
  3. Journal of Biological Chemistry. 2004, NOV 26; 279(48): 49995-50003.
  1. 13.   Correlation between p14(ARF)/p16(INK4A) expression and HPV infection in uterine cervical cancer
  2. Kanao, H.; Enomoto, T.; Ueda, Y.; Fujita, M.; Nakashima, R.; Ueno, Y.; Miyatake, T.; Yoshizaki, T.; Buzard, G. S.; Kimura, T.; Yoshino, K.; Murata, Y.
  3. Cancer Letters. 2004, SEP 15; 213(1): 31-37.
  1. 14.   Regulation of HDM2 activity by the ribosomal protein L11
  2. Lohrum, M. A. E.; Ludwig, R. L.; Kubbutat, M. H. G.; Hanlon, M.; Vousden, K. H.
  3. Cancer Cell. 2003 3(6): 577-587.
  1. 15.   Phosphorylation of HDM2 by Akt
  2. Ashcroft, M.; Ludwig, R. L.; Woods, D. B.; Copeland, T. D.; Weber, H. O.; MacRae, E. J.; Vousden, K. H.
  3. Oncogene. 2002 21(13): 1955-1962.
  1. 16.   Regulation of p53 function
  2. Woods, D. B.; Vousden, K. H.
  3. Experimental Cell Research. 2001 264(1): 56-66.
  1. 17.   C-terminal ubiquitination of p53 contributes to nuclear export
  2. Lohrum, M. A. E.; Woods, D. B.; Ludwig, R. L.; Balint, E.; Vousden, K. H.
  3. Molecular and Cellular Biology. 2001 21(24): 8521-8532.
  1. 18.   Human T-cell leukemia virus type I tax activates transcription of the human monocyte chemoattractant protein-1 gene through two nuclear factor-kappa B sites
  2. Mori, N.; Ueda, A.; Ikeda, S.; Yamasaki, Y.; Yamada, Y.; Tomonaga, M.; Morikawa, S.; Geleziunas, R.; Yoshimura, T.; Yamamoto, N.
  3. Cancer Research. 2000 60(17): 4939-4945.
  1. 19.   Human papillomavirus and cancer: The viral transforming genes
  2. Phillips, A. C.; Vousden, K. H.; Newton, R.; Beral, V.; Weiss, R. A.
  3. Infections and Human Cancer. 1999; 33 : 55-74.
  1. 20.   Mdm2 binds p73 alpha without targeting degradation
  2. Balint, E.; Bates, S.; Vousden, K. H.
  3. Oncogene. 1999 18(27): 3923-3929.
  1. 21.   Analysis of the degradation function of Mdm2
  2. Kubbutat, M. H. G.; Ludwig, R. L.; Levine, A. J.; Vousden, K. H.
  3. Cell Growth and Differentiation. 1999 10(2): 87-92.
  1. 22.   Regulation of p53 stability
  2. Ashcroft, M.; Vousden, K. H.
  3. Oncogene. 1999 18(53): 7637-7643.
  1. 23.   Mice Deficient in Nuclear Factor (Nf)-Kappa-B/P52 Present With Defects in Humoral Responses, Germinal Center Reactions, and Splenic Microarchitecture
  2. Franzoso, G.; Carlson, L.; Poljak, L.; Shores, E. W.; Epstein, S.; Leonardi, A.; Grinberg, A.; Tran, T.; Schartonkersten, T.; Anver, M.; Love, P.; Brown, K.; Siebenlist, U.
  3. Journal of Experimental Medicine. 1998 187(2): 147-159.
  1. 24.   Dispensability of P53 Degradation For Tumorigenicity and Decreased Serum Requirement of Human Papillomavirus Type 16e6
  2. Inoue, T.; Oka, K.; Yongil, H.; Vousden, K. H.; Kyo, S.; Jing, P.; Hakura, A.; Yutsudo, M.
  3. Molecular Carcinogenesis. 1998 21(3): 215-222.
  1. 25.   Regulation of P53 Stability By Mdm2
  2. Kubbutat, M. H. G.; Jones, S. N.; Vousden, K. H.
  3. Nature. 1997 387(6630): 299-303.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel